Phenomic AI is a private platform biotechnology company based in Toronto, Canada. The company specializes in the development of novel antibody-based therapies targeting the tumor stroma and fibrotic diseases. By leveraging advanced artificial intelligence and machine learning tools, the company analyzes complex cell-cell interactions within multi-cell systems to identify new drug targets.
Solid tumors
CTI LSF II
Lead
Director
April 27, 2020
n/a
Series A
Phenomic AI’s platform integrates one of the world's largest single-cell RNA (scRNA) datasets from human tissues, enabling the analysis of complex cell-cell interactions within multi-cell systems
October 7, 2020
November 30, 2023
November 29, 2023
